Serina Therapeutics (SER) Other Non-Current Assets (2017 - 2025)
Historic Other Non-Current Assets for Serina Therapeutics (SER) over the last 9 years, with Q3 2025 value amounting to $24000.0.
- Serina Therapeutics' Other Non-Current Assets fell 9279.28% to $24000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $24000.0, marking a year-over-year decrease of 9279.28%. This contributed to the annual value of $50000.0 for FY2022, which is 0.0% changed from last year.
- Per Serina Therapeutics' latest filing, its Other Non-Current Assets stood at $24000.0 for Q3 2025, which was down 9279.28% from $333000.0 recorded in Q3 2024.
- In the past 5 years, Serina Therapeutics' Other Non-Current Assets ranged from a high of $333000.0 in Q3 2024 and a low of $24000.0 during Q3 2025
- Moreover, its 5-year median value for Other Non-Current Assets was $50000.0 (2021), whereas its average is $67133.3.
- In the last 5 years, Serina Therapeutics' Other Non-Current Assets skyrocketed by 56600.0% in 2024 and then crashed by 9279.28% in 2025.
- Serina Therapeutics' Other Non-Current Assets (Quarter) stood at $50000.0 in 2021, then changed by 0.0% to $50000.0 in 2022, then changed by 0.0% to $50000.0 in 2023, then surged by 566.0% to $333000.0 in 2024, then crashed by 92.79% to $24000.0 in 2025.
- Its Other Non-Current Assets stands at $24000.0 for Q3 2025, versus $333000.0 for Q3 2024 and $50000.0 for Q2 2024.